UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets

Pharmacological research, 2019-06, Vol.144, p.192-209

2019

Link zum Volltext

Verfügbarkeit prüfen

Impaired immune surveillance accelerates accumulation of senescent cells and aging

Nature communications, 2018-12, Vol.9 (1), p.5435-15, Article 5435

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

The New England journal of medicine, 2021-11, Vol.385 (20), p.1845-1855

2021

Link zum Volltext

Verfügbarkeit prüfen

EZH2: a novel target for cancer treatment

Journal of hematology and oncology, 2020-07, Vol.13 (1), p.104-12, Article 104

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

European heart journal, 2016-06, Vol.37 (21), p.1671-1680

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-11, Vol.326 (19), p.1919

2021

Link zum Volltext

Verfügbarkeit prüfen

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.372-381

2018

Link zum Volltext

Verfügbarkeit prüfen

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

International journal of molecular sciences, 2018-08, Vol.19 (8), p.2362

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological interventions for apathy in Alzheimer's disease

Cochrane database of systematic reviews, 2018-05, Vol.5 (5), p.CD012197

2018

Link zum Volltext

Verfügbarkeit prüfen

Insights on the Multifunctional Activities of Magnolol

BioMed research international, 2019-01, Vol.2019, p.1847130-15

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol

Circulation (New York, N.Y.), 2021-06, Vol.143 (25), p.2431-2440

2021

Link zum Volltext

Verfügbarkeit prüfen

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

Circulation (New York, N.Y.), 2016-03, Vol.133 (11), p.1115-1124

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis

Oncogene, 2020-10, Vol.39 (42), p.6589-6605

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

Diabetes care, 2016-07, Vol.39 (7), p.1241-1249

2016

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure

Journal of the American College of Cardiology, 2023-07, Vol.82 (1), p.1-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Journal of hypertension, 2001-10, Vol.19 (10), p.1783-1787

2001

Link zum Volltext

Verfügbarkeit prüfen

Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis

Cardiovascular drugs and therapy, 2021-10, Vol.35 (5), p.1067-1076

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer

Drug safety, 2019-02, Vol.42 (2), p.263-279

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results

International journal of cardiology, 2024-04, Vol.400, p.131706-131706, Article 131706

2024

Link zum Volltext

Verfügbarkeit prüfen

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

The New England journal of medicine, 2008-12, Vol.359 (23), p.2456-2467

2008

Link zum Volltext

Verfügbarkeit prüfen

Honokiol: a novel natural agent for cancer prevention and therapy

Current molecular medicine, 2012-12, Vol.12 (10), p.1244

2012

Link zum Volltext

Verfügbarkeit prüfen

Bcl-2-regulated apoptosis: mechanism and therapeutic potential

Current Opinion in Immunology, 2007-10, Vol.19 (5), p.488-496

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.735

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.373)
Mit Volltextzugriff
(2.108)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.150)
Life Sciences & Biomedicine
(2.085)
Biphenyl Compounds - Therapeutic Use
(1.971)
Humans
(1.961)
Male
(1.303)
Tetrazoles - Therapeutic Use
(1.112)
Animals
(1.101)
Female
(928)
Biological And Medical Sciences
(736)
Medical Sciences
(720)
Pharmacology & Pharmacy
(709)
Antihypertensive Agents - Therapeutic Use
(708)
Biphenyl Compounds - Pharmacology
(663)
Hypertension - Drug Therapy
(660)
Middle Aged
(640)
Aged
(561)
Cardiovascular System & Cardiology
(555)
Pharmacology. Drug Treatments
(525)
Rats
(486)
Biphenyl Compounds
(405)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(20)

Menü

Weitere Dienste

Einstellungen

Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets

Impaired immune surveillance accelerates accumulation of senescent cells and aging

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

EZH2: a novel target for cancer treatment

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

Pharmacological interventions for apathy in Alzheimer's disease

Insights on the Multifunctional Activities of Magnolol

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial

Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis

Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer

Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

Honokiol: a novel natural agent for cancer prevention and therapy

Bcl-2-regulated apoptosis: mechanism and therapeutic potential

Suchergebnisse filtern